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The poor self-healing ability of cartilage necessitates the development of methods for car-
tilage regeneration. Scaffold construction with live stem cell incorporation and subsequent
differentiation presents a promising route. Projection stereolithography (PSL) offers high
resolution and processing speed as well as the ability to fabricate scaffolds that precisely fit
the anatomy of cartilage defects using medical imaging as the design template. We report
here the use of a visible-light-based PSL (VL-PSL) system to encapsulate human adipose-
derived stem cells (hASCs) into a biodegradable polymer [poly-D,L-lactic acid/polyethylene
glycol/poly-D,L-lactic acid (PDLLA-PEG)]/hyaluronic acid (HA) matrix to produce live cell
constructs with customized architectures. After fabrication, hASCs showed high viability
(84%) and were uniformly distributed throughout the constructs, which possessed high
mechanical properties with a compressive modulus of 780 kPa. The hASC-seeded
constructs were then cultured in control or TGF-β3-containing chondrogenic medium
for up to 28 days. In chondrogenic medium-treated group (TGF-β3 group), hASCs
maintained 77% viability and expressed chondrogenic genes Sox9, collagen type II, and
aggrecan at 11, 232, and 2.29105 fold increases, respectively compared to levels at
day 0 in non-chondrogenic medium. The TGF-β3 group also produced a collagen type
II and glycosaminoglycan-rich extracellular matrix, detected by immunohistochemistry,
Alcian blue staining, and Safranin O staining suggesting robust chondrogenesis within
the scaffold. Without chondroinductive addition (Control group), cell viability decreased
with time (65% at 28 days) and showed poor cartilage matrix deposition. After 28 days,
mechanical strength of the TGF-β3 group remained high at 240 kPa. Thus, the PSL
and PDLLA-PEG/HA-based fabrication method using adult stem cells is a promising
approach in producing mechanically competent engineered cartilage for joint cartilage
resurfacing.
Keywords: adipose stem cells, cartilage tissue engineering, PDLLA-PEG, projection stereolithography, live
cell-scaffold fabrication
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Introduction
Cartilage damaged by trauma, disease, or aging demonstrates very
limited capabilities for self-regeneration and ultimately results in
osteoarthritis (OA) (Tuan et al., 2013). Given the high prevalence
of OA in the United States (27 million affected) (Zhang and
Jordan, 2010), which is projected to increase due to population
aging as well as the obesity epidemic, methods toward manag-
ing and treating these cartilage defects are critical. While there
exist procedures to treat these defects, such as microfracture and
osteochondral grafting, they either finally lead to the formation
of fibrocartilage or are limited by tissue availability (Moriya et al.,
2007; Gigante et al., 2011; Ye et al., 2013). In addition, allografting
bone and cartilage have the potential risk of infection and disease
transmission. Severe cartilage defects ultimately require total joint
arthroplasty to reduce pain and improvemobility, but this involves
amajor surgery and ends the biological life of cartilage (Moran and
Horton, 2000; Nashi et al., 2014). As such, a regenerative approach
that can restore the native properties of cartilage represents an
attractive alternative.
Recently, regenerative medicine has garnered high interest,
which involves the development of cartilage-like constructs
through the use of cells, growth factors, scaffolds, and combi-
nations (Tuan et al., 2013; Demoor et al., 2014). For example,
autologous chondrocyte implantation (ACI) and matrix-induced
ACI (MACI) are popular procedures that harvest and expand
chondrocytes in vitro from the patient’s own tissue, which are then
grafted into the cartilage defect site with or without accompany-
ing extracellular matrix (ECM). However, this source of healthy
chondrocytes is limited and requires several weeks of cell cultur-
ing to obtain adequate cell numbers for transplantation, which
results in chondrocyte dedifferentiation (Kuo et al., 2006). Thus,
adult tissue-derived stem/progenitor cells, such as mesenchymal
stem cells (MSCs), that have been shown to have the ability to
differentiate into a variety of cell lines including chondrocytes
(Pittenger et al., 1999) offer a promising substitute for the primary
chondrocytes. In particular, adipose tissue-derived MSCs (ASCs)
have attracted recent attention because they are isolated in higher
quantities than stem cells found from other sources, such as bone
marrow, and are obtainable through minimally invasive proce-
dures, thus offering the advantage of reducing or even eliminating
in vitro expansion to allow point-of-care application (Roux et al.,
2013). In addition, ASCs have been shown to be beneficial in
cartilage healing, including reducing pain and improving function
for aging patients with knee OA after intra-articular injection
(Koh et al., 2013).
A key component in cartilage tissue engineering is a biomaterial
scaffold to deliver the candidate cells, such as MSCs, to the defect
site and to also temporarily fill the defect to facilitate cell growth.
In addition to biocompatibility, the ideal scaffold for cartilage
tissue engineering should possess viscoelastic hydrogel-like char-
acteristics that mimic the mechanical properties and functions of
native cartilage. Optimally, the biomaterial will also be biodegrad-
able such that as the stem cells differentiate into chondrocytes
and produce a cartilaginous ECM, the scaffold degrades and the
newly secreted ECM remodels the construct into a cartilage-like
tissue. In addition, precise fitting of the scaffold into the local
structural geometry of the defect and the host tissue anatomy is
critical for enhancing the repair process such that the absence of
gaps will optimize integration between implants and native tissue
and allow continuous load distribution (Da Silva et al., 2012). To
date, many technologies have been developed in the fabrication of
scaffolds with different geometry and internal architecture. Tradi-
tional technologies, such as solvent casting, particulate leaching,
and electrospinning, do allow for limited control of structure, but
they are not able to perform the fabrication of highly detailed
structures on a patient by patient basis (Yang et al., 2001). In
addition, these methods require the use of either organic solvents
or conditions unfavorable for cell survival, thereby limiting their
ability to seed cells directly within scaffolds (Yang et al., 2002;
Derby, 2012).
Solid free-form fabrication (SFF) methods have been shown
to offer the ability to control both the macrostructure as well
as the microstructure of scaffolds. With the utilization of med-
ical imaging and computer-aided design (CAD) model guided
scaffold fabrication, SFF methods can create scaffolds with pre-
cise architectures (Bajaj et al., 2012). Different SFF methods
have been applied in the fabrication of a variety of biomateri-
als, including laser sintering, stereolithography, fused deposition
modeling, and 3D printing. Of these techniques, stereolithogra-
phy is the most accurate and is based on light-induced photo-
polymerization of derivatized monomers (Melchels et al., 2010).
Projection stereolithography (PSL) in particular is a method
that has been attracting increased interest due to its high fab-
rication rate and resolution. By utilizing a layer-by-layer-based
image projection of defined thickness, fabrication times are dras-
tically reduced from conventional stereolithography. Recently,
in our laboratory, PSL using visible-light illumination (VL-PSL)
has been applied in a one-step live cell-scaffold fabrication in
which highly viable human adipose-derived stem cells (hASCs)
were uniformly incorporated within polyethylene glycol diacry-
late (PEGDA) scaffolds (Lin et al., 2013). While this proce-
dure for the first time allows live cell-scaffold fabrication using
VL-PSL, it is currently limited by the monomer that is used
because PEG is not biodegradable and does not provide cell-
binding ligands. In addition, Percoll was used to suspend the
cells during the fabrication, which introduces additional non-
native molecules into the final construct. The extent to which
chondrogenesis of hASCs is supported in the PEG scaffold was
also not investigated.
A number of properties are desirable for a biomaterial suitable
for implantation for cartilage repair, including biodegradability,
biocompatibility, strong compressive modulus, and presence of
cell-binding ligands. Most importantly, the material must also be
water-soluble in order to not interfere with cell survival during the
photo-crosslinking scaffold fabrication process. We report here
the identification of a novel hybrid matrix in which the synthetic
polymer, poly-,-lactic acid/polyethylene glycol/poly-,-lactic
acid (PDLLA-PEG), served as the structural component (Seck
et al., 2010), and hyaluronic acid (HA) as the co-polymer to supply
cell-binding ligands and to inhibit cell settlement during PSL fab-
rication owing to its viscous property. HA is a glycosaminoglycan
(GAG) present in abundance in the cartilage ECM and synovial
fluid and has been shown to promote hASC chondrogenesis
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through interaction with its surface receptor, CD44 (Wu et al.,
2013; Chopra et al., 2014).
In this study, hASCs were suspended in a methacrylated
PDLLA-PEG and HA (mPDLLA-PEG) solution and subjected to
VL-PSL with different CAD architectures. The cell-seeded fab-
ricated scaffolds were cultured in control medium or TGF-β3-
containing chondrogenic medium for up to 4weeks. Cell viability
was examined at different time points and the progression of
chondrogenesis of hASCs within the scaffolds was assessed by
mechanical testing, real time reverse transcription polymerase
chain reaction (RT-PCR) analysis of gene expression, and his-
tological staining. Our results showed that the VL-PSL pro-
duced hybrid scaffolds preciselymimicked the CAD structure and
maintained high cell viability during the fabrication process. In
addition, mPDLLA-PEG/HA scaffolds supported efficient hASC
chondrogenesis upon induction. Thus, the method described in
this report represents a promising method for the development of
personalized stem cell-based repair of articular cartilage defect.
Materials and Methods
All chemicals were purchased from Sigma-Aldrich (St. Louis,MO,
USA) unless otherwise stated.
Human Adipose Stem Cell Isolation
Human adipose-derived stem cells were isolated from lipoaspirate
with Institutional Review Board approval (University of Pitts-
burgh and University of Washington) using an automated cell
isolation system from Tissue Genesis, Inc. (Honolulu, HI, USA).
The isolated cell pellets were re-suspended in expansion medium
(EM:DMEM-high glucose, 10%MSC-certified fetal bovine serum
(FBS), 100U/ml penicillin, 100μg/ml streptomycin; Invitrogen,
Carlsbad, CA, USA) and plated on tissue culture flask. After
3 days, the non-attached cells were washed out with Hank’s Bal-
anced Salt Solution (HBSS). The medium was changed every
3 days. At 80% confluence, cells were detached with 0.25% trypsin
in 1mM EDTA (Invitrogen) and passaged. All experiments were
performed with hASCs obtained at passage 3 (P3). hASCs used
in this study were pooled from two patients (36- and 28-year
females).
Synthesis of Methacrylated PDLLA-PEG and HA
Preparation of the mPDLLA-PEG was performed as described
by Seck et al. (2010). Briefly, 50 g of PEG (4 kDa molecular
weight) was placed into a 250ml Erlenmeyer flask and subjected
to 600W microwave irradiation for 3min. Subsequently, 3.5 g
(2.80ml) of stannous octoate [Sn(Oct)2] was added to the molten
PEG followed by addition of 7.2 g poly-,-lactide. The mixture
was subjected to 600W microwave irradiation for 1min. The
initial PDLLA-PEG polymer was precipitated in 500ml cold iso-
propanol, and was dried under vacuum for 2 days. Dry polymer
was dissolved in 100ml dichloromethane (DCM), followed by
addition of three equivalents of triethylamine (TEA, ~5.25ml)
and three equivalents of methacrylic anhydride (MA, ~5.60ml).
The reaction mixture was covered with punctured Parafilm and
allowed to stir at room temperature for 7 days. After completion
of the reaction, themixture was precipitated into diethyl ether. For
further purification, the macromer was redissolved in minimal
amounts of chloroform and reprecipitated in diethyl ether.
Methacrylated hyaluronic acid was prepared by reacting
MA with sodium hyaluronate (research grade, MW ~700 kDa,
Lifecore, Chaska, MN) (Chung et al., 2009).
Synthesis of Photoinitiator LAP
The visible-light sensitive initiator lithium phenyl-2,4,6-
trimethylbenzoylphosphinate (LAP) was synthesized as described
by Fairbanks et al. (2009).
PSL Fabrication of Live Cell Constructs
The PSL apparatus was purchased from EnvisionTec (Perfactory
Standard, Gladbeck, Germany) equipped with digital light pro-
cessing (DLP) technology. Visible-light mode (Hg illumination
utilizing a UV barrier filter) was used, with the curing depth of
each layer set at 50μm.
Solutions of polymer, LAP, and phenol red dye were prepared
in 50ml tubes. Thirty percent PDLLA-PEG was chosen because
it not only maintained the fabrication fidelity of VL-PSL but
also formed a scaffold with mechanical properties more similar
to that of cartilage. HA was used at 0.5% concentration because
it yielded sufficient specific gravity to suspend cells but did not
compromise routine cell mixing by trituration, for example, by
repeated pipetting. For instance, the preparation of mPDLLA-
PEG (30%w/v),mHA (0.5%w/v), LAP (0.6%w/v), and phenol red
(0.025% w/v) was carried out as follows: polymer (12 g mPDLLA-
PEGand 0.2 gmHA)was placed in the 50ml tube followed by slow
addition of HBSS close to the 40mlmark and subsequent addition
of LAP (240mg) and phenol red (10mg). The solutionwas titrated
to pH 7.4 with 10N NaOH and adjusted to 40ml using HBSS.
P3 hASCs were pelleted by centrifugation, and the supernatant
was completely removed. The polymer solution prepared above
was added on top of the pellets and mixed with cells thoroughly
by gently pipetting up and down 20 times. The final hASC density
was 4 106 cells/ml. After the bubbles were removed by aspira-
tion, the cell-polymer solution was immediately poured into the
basement plate of the PSL device for printing with different 3D
models as the template, using our recently described procedure
(Lin et al., 2013).
The fabricated constructs were detached from the platform and
washed three times to remove uncured polymer solution. The
constructs were cultured in controlmedium [CM,DMEMwith1%
-alanyl--glutamine (GlutaMAX), 55μM sodium pyruvate,
1 antibiotic-antimycotic, and 1% insulin–transferrin–selenium
(ITS) (Invitrogen, Carlsbad, CA, USA)] or chondrogenic medium
[CGM, CM supplemented with 10 ng/ml transforming growth
factor-β3 (TGF-β3; PeproTech, Rocky Hill, NJ, USA], 100 nM
dexamethasone, 50μM -ascorbic acid 2-phosphate, and 23μM
-proline) up to 28 days, which were designated as control or
TGF-β3 group, respectively.
Degradation Test
Fabricated scaffolds (5mm diameter and 2mm height) produced
as described above but without cells were immersed in 5ml HBSS
and maintained in cell culture incubator at 37°C. HBSS was
changed every 3 days. Since our ultimate goal was to apply the
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org August 2015 | Volume 3 | Article 1153
Sun et al. PSL-fabricated matrices for cartilage regeneration
engineered tissue constructs for articular cartilage repair in vivo,
their functional characteristics, particularly in terms of mechan-
ical property, were of critical importance. Therefore, the degra-
dation of polymer was estimated by measuring the mechanical
property of scaffolds at different times.
Mechanical testing of scaffolds was conducted with a mechan-
ical tester (Bose Electroforce model 3230 Series II). Briefly, the
cylindrical scaffolds were placed between the compressive motor
and load cell and subjected to 10% compression (0.2mm) at
0.01mm/s. The stress–strain curve was then plotted, and the
linear area was used to calculate the compressive modulus of
scaffolds.
Live/Dead Staining
At various time points post-fabrication, cell viability was assessed
with the live/dead viability/cytotoxicity kit (Invitrogen) as exam-
ined by epifluorescence microscopy following the product man-
ual. The percentage of live cells was calculated as the number of
green-staining cells divided by the total number of cells (green and
red staining cells).
MTS Assay
On days 0 and 28, cell metabolic activity was assessed with
CellTiter 96® AQueous One Solution Cell Proliferation Assay [3-
(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-su
lfophenyl)-2H-tetrazolium, inner salt; MTS, Promega, Madison,
WI, USA]. The constructs with cells were cultured with MTS
solution for 4 h, and absorbance at 492 nm was measured using a
microplate reader (BioTek, Winooski, VT, USA).
Analysis of Gene Expression by Real-Time
RT-PCR
Total RNA of the cells within the constructs was isolated using
TRIZOL reagent (Invitrogen) and purified using RNeasy Plus
Mini Kit (Qiagen, Germantown, MD, USA). Reverse transcrip-
tion reactions were performed using SuperScript® VILO™ cDNA
Synthesis Kit (Invitrogen) according to manufacturer’s manual.
Real-time PCR was performed using the SYBR Green Reaction
Mix (Applied Biosystems, Foster City, CA, USA) with a StepOne-
Plus thermocycler (Applied Biosystems). All sample values were
normalized to 18S rRNA using the 2 ΔΔCt method.
Hydroxyproline Quantitation
Total collagen content deposited within the constructs was deter-
mined bymeasuring hydroxyproline levels. The constructs (5mm
diameter and 2mm thickness) were homogenized in water by
grinding and hydrolyzed using the same volume of 12N HCl
(Fisher, Pittsburgh, PA, USA) at 120°C for 3 h. Hydroxyproline
content in constructs was quantitated using a Hydroxyproline
Colorimetric Assay Kit (BioVision, San Francisco, CA, USA).
Histology
After 28 days culture, constructs were removed from the incu-
bator, washed twice, and fixed in buffered paraformaldehyde
(4%, Fisher) for 1 day at room temperature. After washing with
PBS three times, they were then cryosectioned using a cryostat
(CM1520, Leica) at 8μm thickness. For assessment of GAG depo-
sition, the slides were stained with either Alcian Blue or Safranin
O/Fast Green following standard protocols. Images were captured
with a CKX41 microscope (Olympus, Japan) equipped with a
Leica DFC 3200 camera.
Immunohistochemistry
Enzymatic antigen retrieval was performed using chondroiti-
nase/hyaluronidase (1 and 5mg/ml) at 37°C for 30min, and was
suppressed with 1% horse serum (Vector Labs, Burlingame, CA,
USA) in PBS for 45min. After blocking endogenous peroxidase
(3% H2O2 in methanol for 10min) and non-specific binding
[1% horse serum (Vector Labs)], slices were incubated with pri-
mary antibodies against collagen type II (Abcam, Cambridge,
MA, USA) overnight at 4°C. After washing, biotinylated sec-
ondary antibodies (Vector Labs) were applied for 30min. Staining
was developed by treating samples with horseradish peroxidase
(HRP)-conjugated streptavidin/NovaRED™ peroxidase substrate
(Vector Labs).
Mechanical Property Assessment
The mechanical property of constructs at days 0 and 28 were
measured using the procedure described before.
Statistical Analysis
All studies were performed with three experimental replicates.
Results were expressed as the mean SD. Significant differ-
ences between control and chondrogenic groups were deter-
mined by one-tailed Student’s t-test. Significance was considered
at p< 0.05* and p< 0.01**.
Results
Constructs generated using VL-PSL were first assessed for their
ability to faithfully replicate designed architectures. Figure 1
illustrates the construction of various 3D shapes, including con-
ical, cubic, and cylindrical (Figures 1A,B), and more complicated
alpha numeric structures (Figures 1C,D). In all cases, the struc-
tures produced using VL-PSL mimicked the designs with high
fidelity upon visual inspection.
Degradation Analysis
Due to the presence of ester bonds in the mPDLLA-PEG/HA
co-polymers, the scaffolds are expected to be degraded through
hydrolytic cleavage (Seck et al., 2010). To test the degradation
behavior, PSL-fabricated mPDLLA-PEG/HA scaffolds were incu-
bated in PBS at 37°C and their mechanical properties tested at
different time points up to 4weeks. As shown in Figure 2, the
compressive modulus of scaffolds significantly decreased with
time, demonstrating structural degradation in aqueous solution.
After 4weeks, scaffolds retained only ~25% of their original
mechanical strength but still maintained the original cylindrical
structure.
Cell Viability Assessment
Cell viability was determined immediately after fabrication and
also at 28 days after culturing in control and chondrogenic
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org August 2015 | Volume 3 | Article 1154
Sun et al. PSL-fabricated matrices for cartilage regeneration
FIGURE 1 |mPDLLA-PEG constructs generated using VL-PSL.
(A,B) PDLLA-PEG hydrogels with spherical, cuboidal, and cylindrical
architecture (B) based on CAD models (A). (C,D) Alphanumeric
mPDLLA-PEG hydrogels (D) based on CAD models (C). Formulation used
includes mPDLLA-PEG (30% w/v), mHA (0.5% w/v), LAP (0.6% w/v), and
phenol red (0.025% w/v).
medium. Figure 3A shows a surface view of a Calcein-AM stained
construct, and Figure 3B shows a cross-sectional view of the
construct at day 0. Uniform distribution of single cells throughout
the construct was clearly seen, suggesting that cells remained sus-
pended and separated from each other in the fabrication solution
for at least 30min. Cell viability was determined to be high at
81% after fabrication (Figures 3C,D,I). After 28 days of culture in
control medium, cell viability decreased to 65% (Figures 3E,F,I,J).
In contrast, chondrogenic medium supplemented with TGF-β3
not only maintained higher cell viability (77%, Figures 3G–I)
but also promoted higher overall cell metabolic activity as indi-
cated by MTS assay (Figure 3J). There is a statistically significant
difference between the control and the TGF-β3 group in cell
number.
Chondrogenesis Analysis
Chondrogenic differentiation of the hASCs seeded within the
dense mPDLLA-PEG/HA scaffolds and exposed to TGF-β3-
containing chondrogenic medium was analyzed by real time
RT-PCR for the expression of genes associated with chondro-
genesis. Figures 4A–D show the relative levels of gene expres-
sion for Sox 9, aggrecan, collagen type II, and Runx2. All
three chondrogenic genes, Sox 9, aggrecan, and collagen II,
were also considerably higher in the TGF-β3 group. In con-
trast, Runx2, an osteogenesis marker, expression was found to be
higher in the control group. Thus, TGF-β3 chondrogenicmedium
effectively induced chondrogenesis and concurrently inhibited
osteogenesis in hASCs encapsulated within the PSL-fabricated
scaffolds.
The chondrogenic activity of the cells within the constructs
cultured in the chondrogenic medium was next assessed based on
hydroxyproline assay to estimate the content of newly synthesized
FIGURE 2 |Mechanical property of mPDLLA-PEG/HA scaffolds
incubated in HBSS at 37°C for different times up to 28days. Difference
between every two groups is statistically significant.
collagen. The TGF-β3 group showed a hydroxyproline level of
21.16 7.15μg/construct versus an undetectable level in the con-
trol group (Figure 5). Since this assay did not differentiate between
the different collagen types, we further performed immunohis-
tochemistry (IHC) to examine the presence of collage type II.
IHC revealed positive staining for collagen type II, a major ECM
component in cartilage, only in the TGF-β3 group (Figure 6).
GAG and proteoglycan content were also estimated by histo-
logical staining with Alcian Blue and Safranin O, respectively.
Weak staining was seen in the control group after 28 days culture
(Figures 7A,C), while dense, strong staining was seen in the TGF-
β3 group (Figures 7B,D). Taken together, these results clearly
demonstrate that with TGF-β3 induction, robust chondrogenic
differentiation of the hASCs took place within the PSL-fabricated
constructs.
Lastly, the compressive moduli for the constructs containing
the mPDLLA-PEG polymer were measured. At day 0, the com-
pressive modulus was 780 23 kPa, which fell to 240 20 kPa in
the control group and 238 25 kPa in the TGF-β3 group by day
28 (Figure 8), principally due to the degradation of the scaffold
material.
Discussion
This study reported the application of a VL-PSL protocol to
fabricate live hASC-laden, biodegradable polymeric mPDLLA-
PEG/HA constructs with cartilage-like mechanical properties.
Within the photocrosslinked constructs, cells were uniformly dis-
tributed and underwent robust chondrogenesis upon TGF-β3
stimulation, suggesting the potential application of this technol-
ogy for cartilage tissue repair.
Tissue engineering has been considered a promising approach
to repair degenerated articular cartilage in degenerative joint dis-
eases, such as OA. The goal has been to construct or regenerate
tissues that possess the properties of native cartilage, but cur-
rently there are many technical challenges. First, articular car-
tilage is an avascular tissue, which limits the ability of cells of
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FIGURE 3 | Cell viability in VL-PSL generated mPDLLA-PEG scaffolds at
0 and 28days after fabrication. (A–C,E,G) Calcein-AM staining (green, live
cells) and (D,F,H) EthD-1 staining (red, dead cells) in scaffold demonstrate the
cell viability following fabrication throughout VL-PSL method. Cells were seen to
be uniformly distributed at different layers. (I) Based on live/dead staining results,
cell viability at days 0 and 28 in control as well as TGF-β3 group was calculated.
(J) MTS assay of constructs at days 0 and 28 in control as well as TGF-β3
group. Scale bars: (A) 1mm; (B) 500μm; and (C–H) 100μm. *p<0.05.
FIGURE 4 | Real time-PCR analysis of gene expression in hASCs at day 28 in 2D tissue culture plate, control group, and TGF-β3 group. Relative gene
expression levels of (A) Sox 9, (B) aggregan, (C) collagen type II, and (D) Runx2 at day 28, are normalized to gene expression in 2D culture without chondrogenic
induction. *p<0.05.
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FIGURE 5 | Hydroxyproline levels in hASC-encapsulated
VL-PSL-fabricated constructs in the control and TGF-β3 groups at
days 0 and 28. Levels of hydroxyproline in days 0 and 28 control groups
were negligible, and levels in the day 28 TGF-β3 group measured at
21.167.15μg/construct. **p<0.01.
surrounding tissues to infiltrate the defect site following implan-
tation of the engineered tissue implant. Thus, a uniform cell
distribution throughout the scaffold that makes up the construct
is required so that tissue repair can occur within the entire
scaffold and not be confined to the superficial zones. A second
challenge is the mechanical environment within the articular
joint environment, namely the natural high loads that any scaf-
fold or neo-tissue must withstand. The scaffold thus needs to
be inherently mechanically stiff immediately following grafting.
A third challenge is that articular cartilage defects, by trauma-
induced loss or chronic osteoarthritic lesions, are irregular in
shape, which makes moldable cell-seeded materials desirable. No
currently available hydrogel materials have completely met these
requirements.
Recently, our group introduced a visible-light-based PSL
method for live cell-scaffold fabrication. Utilizing this technol-
ogy, live cells were uniformly distributed within scaffolds with
designed architectures. While this presented progress toward the
first and third challenges, the chondrogenic potential of con-
structs was not tested. In addition, the PEG material used is
non-biodegradable and does not allow for conversion to native
cartilage tissue. Given the limitations of the PEG methacrylate
hydrogel, we seek to develop a biomaterial that possesses the
ability to be applied in VL-PSL (biocompatibility and water-
solubility) as well as exhibits both higher mechanical strength and
biodegradability. We have identified PDLLA-PEG as a material
that possesses these properties. We then further use highMWHA
(>700 kDa) to replace Percoll to maintain hASCs in suspension
during fabrication, which not only eliminates the presence of
Percoll but also provides native cell-binding ligands. The results
in Figure 3B clearly demonstrate that cells remain sufficiently
suspended uniformly throughout the scaffold during the 30-min
fabrication time.
Even without TGF-β3 stimulation, hASCs cultured in PDLLA-
PEG/HA scaffolds showed increased chondrogenic gene expres-
sion (Figure 4). Since PDLLA-PEG is an inert material like
agarose and alginate, it is reasonable to speculate that this effect
resulted from the inclusion of HA and a 3D culture environ-
ment (Wu et al., 2010; Schagemann et al., 2013). With TGF-β3
supplementation, hASCs showed robust chondrogenesis indicated
by enhanced chondrogenic gene expression and cartilage ECM
deposition. Because of the different types of supplemented TGF-
β, and variable cell density, culture duration, nature of scaffold,
and size of constructs used, no previous data are available for
direct comparison to our results. In one study using TGF-β3
treatment for 21 days, collagen type II and aggrecan expression
in hASCs encapsulated within fibrin increased 50- and 5-fold,
respectively (Park et al., 2011), compared to the 220- and 12-fold
increased observed here in PDLLA-PEG/HA, strongly suggesting
the chondroinductive property of PDLLA-PEG/HA.
The scaffolds constructed using mPDLLA-PEG/HA are found
to rapidly degrade in aqueous solution (Figure 2), which agree
with previous report (Seck et al., 2010). Currently, there are rela-
tively limited studies investigating the degradation behavior of this
material. Yang et al. reported that half of a PDLLA-PEG (4:1, w/w)
scaffold was degraded in 5 days (Yang and Kao, 2006). The relative
slow degradation rate of scaffold used in our studymight be due to
lower PDLLA:PEG ratio and inclusion of photocrosslinkable HA.
After 12weeks of culture in HBSS, the scaffolds still maintain the
original architecture (data not shown).
Even with slower degradation rates, the scaffolds lose 75%
of their strength in 4weeks (Figure 2). However, they are still
stronger (160 kPa compressive modulus) than commonly used
hydrogels, such as agarose, alginate, and gelatin, which have
compressive moduli lower than 30 kPa (Byers et al., 2008; Sto-
jkovska et al., 2010; Lin et al., 2014). While this result indicates
goodmechanical properties ofmPDLLA-PEG/HA, it also suggests
relatively limited matrix deposition by the encapsulated hASCs
(240 kPa compressive modulus at 28 days). Several reasons could
account for this limited matrix deposition: (1) cell death during
culture, (2) insufficient cell number, and (3) inadequate ECM syn-
thesis. As shown in Figure 3J, cell metabolic activity did decrease
after 28 days of culture. In the control group, the cell viability
is low (65%), which might be due to limited nutrient exchange
through the dense scaffolds, a generic deficiency of hydrogel
scaffolds with high mechanical properties. However, the addition
of TGF-β3 maintains cell survival (77%). In addition, together
with the enhanced levels of gene expression of Sox 9, aggrecan,
and collagen type II as well as the presence of collage type II
protein, GAGs, and proteoglycan, we conclude that TGF-β3 is
able to diffuse into the scaffolds and act to stimulate the encap-
sulated cells. The observation of metabolic activity reduction in
the TGF-β3 group might be due to the relatively low metabolic
activity of chondrogenically differentiated hASCs in serum-free
environments compared to the naïve hASCs grown in serum-rich
conditions without differentiation stimulation (Xu et al., 2008).
Therefore, we conclude that the insufficient ECM production in
constructs is due to low cell density used during the fabrication
process. To optimize deposition of ECM, in future studies, we
will use higher initial cell loading density and further optimized
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FIGURE 6 | Immunohistochemical staining for collagen type II in hASC-encapsulated VL-PSL-fabricated constructs. (A) Day 0 immediately after
fabrication; (B) day 28 control group; and (C) day 28 TGF-β3 group. Positive collage type II staining (brown) was only seen in the day 28 TGF-β3 treated group as
indicated by arrows. Scale bar: 50μm.
FIGURE 7 | Glycosaminoglycan (GAG) and proteoglycan content in
hASC-encapsulated VL-PSL-fabricated constructs visualized by
Alcian blue and safranin O/fast green staining at day 28. (A,C) Alcian
blue and safranin O staining, respectively, of control group. Negligible
amounts of GAG and proteoglycan are detected. (B,D) Alcian blue and
safranin O staining, respectively, of TGF-β3 group at day 28, showing strong
staining. Scale bar: 50μm.
chondroinductive conditions.Mauck et al. showed that higher cell
density, such as 60 106 cells/ml, resulted in considerably higher
ECM content than lower cell density culture and contributed to
the mechanical property of whole construct (Mauck et al., 2002).
Also, it has been reported that the addition of BMP-6 dramatically
enhanced the matrix production by hASCs (Puetzer et al., 2010).
In summary, we report here a new combination of
biodegradable water-soluble polymers compatible with the
VL-PSL fabrication process that has the ability to accommodate
seeding as well as chondrogenic differentiation of hASCs and
possesses high compressive modulus. Future studies will attempt
to: (1) optimize cell density and differentiation conditions
to accelerate ECM deposition and (2) address the effect of
adding various substituent groups onto the polymer to control
its degradation profile, as well as increase and fine-tune the
mechanical properties of the scaffold.
Conclusion
Using the degradable mPDLLA-PEG/HA matrix, we have suc-
cessfully applied VL-PSL to fabricate scaffolds based on CAD
FIGURE 8 | Compressive moduli of hASC-encapsulated
VL-PSL-fabricated constructs measured at culture days 0 and 28 in
the control and TGF-β3 groups.
models as the template with high fidelity. hASCs were intro-
duced into the scaffolds during the fabrication process and main-
tained high viability. TGF-β3-containing chondrogenic medium
not only enhanced hASC survival but also effectively induced
hASC chondrogenesis, as indicated by increased chondrogenic
gene expression and cartilage ECM deposition. Live cell-based
PSL-fabricated scaffolds developed in this study thus show great
potential in the development of customized repair of cartilage in
degenerative joint diseases, such as OA.
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